Anagliptin
Cat.No:IA3320 Solarbio
CAS:739366-20-2
Molecular Formula:C19H25N7O2
Molecular Weight:383.45
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > AnagliptinCAS:739366-20-2
Molecular Formula:C19H25N7O2
Molecular Weight:383.45
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to yellow Solid
Qty:
Size:
| CAS | 739366-20-2 |
| Name | Anagliptin |
| Molecular Formula | C19H25N7O2 |
| Molecular Weight | 383.45 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | Off-white to yellow Solid |
| Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| SMILES | O=C(C1=CN2C(N=C1)=CC(C)=N2)NCC(C)(NCC(N3[C@H](C#N)CCC3)=O)C |
| Target Point | DPP4 |
| Passage | Metabolic Enzyme&Protease |
| Background | Anagliptin is a highly selective and potent dipeptidyl peptidase 4 (DPP-4) inhibitor. |
| Biological Activity | Anagliptin (SK-0403) is a highly selective, potent, orally active inhibitor of dipeptidyl peptidase 4 (DPP-4), with an IC50 of 3.8 nM, and less selective at DPP-8 and DDP-9 with IC50s of 68 nM and 60 nM, respectively[1]. |
| IC50 | DPP-4 3.8 nM (IC50).DPP-9 60 nM (IC50).DPP-8 68 nM (IC50) |
| Data Literature Source | [1]. Kato N,et al. Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor. Bioorg Med Chem. 2011 Dec 1;19(23):7221-7. [2]. Ervinna N,et al. Anagliptin,a DPP-4 inhibitor,suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013 Mar;154(3):1260-70. [3]. Yano W,et al. Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor,anagliptin,in low-density lipoprotein receptor-deficient mice. J Diabetes Investig. 2017 Mar;8(2):155-160. |
| Unit | Bottle |
| Specification | 2mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download